At Pharmidex, we help drug developers hit their IND submission dates with high-quality, efficient solutions
September 1, 2025
- Designing robust preclinical studies that deliver accurate data the first time.
- Building flexibility into plans to prevent delays when priorities shift.
- Coordinating ADME, PK/PD, and toxicology in parallel to save weeks.
With over 16,000 projects conducted successfully, work with a proven partner from early discovery to regulatory submission.
Our tailored, quality-driven approach keeps your programme on track and your milestones within reach.
Let’s make your IND deadline a milestone you hit with confidence
🌟 Exciting Announcement from Pharmidex ! 🌟 We’re delighted to share that our Head of Business Development, Martin Barrett , will be attending the upcoming conference: ELRIG Drug Discovery 2025 (21–22 October 2025 | Liverpool, UK). Martin will be eager to connect with fellow life-sciences innovators, exchange ideas and explore new collaborations and opportunities to accelerate drug discovery and development. If you’ll be at the event, we’d love to invite you to meet Martin for a chat about how we can work together. See you in Liverpool!
GMP 37th Symposium
Pharmidex will be attending the GMP 37th Symposium
